PRELUDE CAPITAL MANAGEMENT, LLC
Position in ORGO — Organogenesis Holdings Inc.
CIK 1387508
NEW YORK, NY
Position in ORGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,198
+$558 QoQ
Shares Held
14,008
+37.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $20,247,336 across 16 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
154,970 | $5,250,383 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
137,572 | $4,980,106 | |
| 3 | VTRS |
Viatris Inc
|
159,289 | $2,529,509 | |
| 4 | CRON |
Cronos Group Inc.
|
810,163 | $2,252,253 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
50,635 | $1,284,609 | |
| 6 | ZTS |
Zoetis Inc.
|
15,258 | $1,096,439 | |
| 7 | LQDA |
Liquidia Corp
|
10,758 | $857,735 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
12,240 | $424,360 |
All Filings in ORGO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,198 | 14,008 | Shares | Other | 2026-05-15 | |
| 2024-12-31 | $32,640 | 10,200 | Shares | Other | 2025-02-14 | |
| 2023-03-31 | $21,391 | 10,043 | Shares | Other | 2023-06-01 | |
| 2022-12-31 | $43,150 | 16,041 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $58,397 | 18,024 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||